Results 91 to 100 of about 164,903 (149)

Turmeric and <i>Eucalyptus</i> Aqueous Extracts Reduced Inflammation in Macrophage Activation Syndrome (MAS) Mouse Model. [PDF]

J Inflamm Res
Al-Omari MM, Al-Yousef MM, Al-Qaoud KM, Bataineh NM.   +3 more
europepmc   +1 more source

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

European Journal of Rheumatology, 2020
Courtney Crayne, Randy Q. Cron
doaj  

Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still's disease/systemic lupus erythematosus: insights from nine cases. [PDF]

Front Immunol
Chen J, Zhao L, Lin Y, Lian X, Wang H, Gu L, Wang R, Wang X, Ye S, Fu Q.   +9 more
europepmc   +1 more source

T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome. [PDF]

Pediatr Rheumatol Online J
Lam MT, Jiang CL, Lee PY.
europepmc   +1 more source

Intravenous Anakinra for Treating Macrophage Activation Syndrome in Adult-Onset Still's Disease. [PDF]

Eur J Case Rep Intern Med
Bitik B, Şenturk M, Kibaroglu S, Yildirim T, Tezcan ME, Zeyneloglu P, Yucel AE.   +6 more
europepmc   +1 more source

Effective Treatment of Macrophage Activation Syndrome Linked to Systemic Lupus Erythematosus Using Interleukin-1 Inhibitor. [PDF]

Cureus
Barlas N, Kaur IP, Kuzhuppilly Arcilla C, Kaeley GS, Thway M.   +4 more
europepmc   +1 more source

Etiologies and long-term outcome of pediatric hemophagocytic lymphohistiocytosis and macrophage activation syndrome in Taiwan: a single-center retrospective study. [PDF]

Front Immunol
Wang CY, Lee JH, Lee NC, Hu YC, Chang HH, Wang LC, Lin YT, Yang YH, Chiang BL, Yu HH.   +9 more
europepmc   +1 more source